
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Adelas mission is to develop innovative and accessible technologies that harness biology and change the way we diagnose and treat disease. Adelas genome-wide methylation enrichment technology was originally developed by Chief Scientific Officer Dr. Daniel De Carvalho, PhD, at University Health Networks Princess Margaret Cancer Centre. Adela is initially planning to develop the technology for use across the entire cancer continuumfor detection, diagnosis and management of disease
Adela, inc operates in the Biotechnology research industry.
Adela, inc's revenue is 11m - 100m
Adela, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.